Cost-effective strategies according to the first randomized trial comparing MRI breast cancer screening with mammography in women with a familial risk: FaMRIsc. (October 2020) - Tilanus-Linthorst, M.; Geuzinge, A.; Obdeijn, A.I.M.; Rutgers, E.; Mann, R.; Saadatmand, S.; de Roy van Zuidewijn, D.; Tollenaar, R.; Lobbes, M.; Ausems, M.; van 't Riet, M.; Hooning, M.; et al.